Search details
1.
TRAIL+ NK cells control CD4+ T cell responses during chronic viral infection to limit autoimmunity.
Immunity
; 41(4): 646-56, 2014 Oct 16.
Article
in English
| MEDLINE | ID: mdl-25367576
2.
Childhood vaccination and allergy: A systematic review and meta-analysis.
Allergy
; 76(7): 2135-2152, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33569761
3.
Whole-cell pertussis vaccine in early infancy for the prevention of allergy in children.
Cochrane Database Syst Rev
; 9: CD013682, 2021 09 06.
Article
in English
| MEDLINE | ID: mdl-34693993
4.
CpG pretreatment enhances antiviral T-cell immunity against cytomegalovirus.
Blood
; 122(1): 55-60, 2013 Jul 04.
Article
in English
| MEDLINE | ID: mdl-23673858
5.
Infant Whole-Cell Versus Acellular Pertussis Vaccination in 1997 to 1999 and Risk of Childhood Hospitalization for Food-Induced Anaphylaxis: Linked Administrative Databases Cohort Study.
J Allergy Clin Immunol Pract
; 12(3): 670-680, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38182097
6.
Association between pertussis vaccination in infancy and childhood asthma: A population-based record linkage cohort study.
PLoS One
; 18(10): e0291483, 2023.
Article
in English
| MEDLINE | ID: mdl-37792889
7.
Statistical analysis plan for the OPTIMUM study: optimising immunisation using mixed schedules, an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule.
Trials
; 23(1): 121, 2022 Feb 07.
Article
in English
| MEDLINE | ID: mdl-35130946
8.
OPTIMUM study protocol: an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule.
BMJ Open
; 10(12): e042838, 2020 12 17.
Article
in English
| MEDLINE | ID: mdl-33334840
9.
Whole-Cell Pertussis Vaccination and Decreased Risk of IgE-Mediated Food Allergy: A Nested Case-Control Study.
J Allergy Clin Immunol Pract
; 8(6): 2004-2014, 2020 06.
Article
in English
| MEDLINE | ID: mdl-31891824
10.
Protocol for Pertussis Immunisation and Food Allergy (PIFA): a case-control study of the association between pertussis vaccination in infancy and the risk of IgE-mediated food allergy among Australian children.
BMJ Open
; 8(1): e020232, 2018 01 31.
Article
in English
| MEDLINE | ID: mdl-29391374
11.
Innate immunity defines the capacity of antiviral T cells to limit persistent infection.
J Exp Med
; 207(6): 1333-43, 2010 Jun 07.
Article
in English
| MEDLINE | ID: mdl-20513749
12.
rAAV.sFlt-1 gene therapy achieves lasting reversal of retinal neovascularization in the absence of a strong immune response to the viral vector.
Invest Ophthalmol Vis Sci
; 50(9): 4279-87, 2009 Sep.
Article
in English
| MEDLINE | ID: mdl-19357358
13.
Altered primary CD8+ T cell response to a modified virus Ankara(MVA)-vectored vaccine in the absence of CD4+ T cell help.
Eur J Immunol
; 35(12): 3460-7, 2005 Dec.
Article
in English
| MEDLINE | ID: mdl-16245361
14.
Vaccine route, dose and type of delivery vector determine patterns of primary CD8+ T cell responses.
Eur J Immunol
; 35(9): 2532-40, 2005 Sep.
Article
in English
| MEDLINE | ID: mdl-16144036
15.
Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimen.
J Virol
; 79(23): 14822-33, 2005 Dec.
Article
in English
| MEDLINE | ID: mdl-16282482
16.
DNA vaccines against human immunodeficiency virus type 1.
Immunol Rev
; 199: 144-55, 2004 Jun.
Article
in English
| MEDLINE | ID: mdl-15233732
17.
Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population.
Int Immunol
; 14(1): 31-7, 2002 Jan.
Article
in English
| MEDLINE | ID: mdl-11751749
Results
1 -
17
de 17
1
Next >
>>